Bivatuzumab (Anti-CD44v6)

Ask supplier a question | View on supplier's website

Bivatuzumab (Anti-CD44v6) is a humanized monoclonal antibody targeting against CD44v6 that could acts as a sarcoma target for CAR-redirected CIK cells. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2555
Sku #	A2555-1mg*5
Pricing	1mg*5, $790.00

Feedback